December 3, 2014
Takata Seiyaku obtained on December 1 the marketing authorization rights in Japan from MSD K.K. for two of its active pharmaceutical ingredients (APIs)/six products, it said on the same day. Product shipments are planned for January 13, 2015. The products,...read more